NCT03406260View on ClinicalTrials.gov

A Study of Lasmiditan in Healthy Elderly Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

April 13, 2018

Study Completion Date

April 13, 2018

Conditions
Healthy
Interventions
DRUG

Lasmiditan

Administered orally.

DRUG

Placebo

Administered orally.

Trial Locations (2)

32117

Covance Clinical Research Inc, Daytona Beach

53704

Covance Clinical Research Inc, Madison

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03406260 - A Study of Lasmiditan in Healthy Elderly Participants | Biotech Hunter | Biotech Hunter